12 Health Care Stocks Moving In Wednesday's After-Market Session
Portfolio Pulse from Benzinga Insights
In Wednesday's after-market session, health care stocks saw significant movements. Pulmonx, Butterfly Network, Compass Therapeutics, Sharps Technology, Blueprint Medicines, and Asensus Surgical were among the gainers, with Pulmonx leading at a 29.5% increase following their Q1 earnings release. Conversely, Envista Holdings, Accuray, Allakos, Psyence Biomedical, Schrodinger, and Indaptus Therapeutics experienced declines, with Envista Holdings dropping 12.5% after their Q1 earnings announcement.
May 01, 2024 | 8:31 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Accuray's shares fell 12.45% to $1.9 following the Q3 earnings report, with a market value of $188.4 million.
Accuray's stock price decline is a direct consequence of their Q3 earnings announcement, suggesting the market reacted negatively to the news.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 90
NEGATIVE IMPACT
Envista Holdings saw a 12.5% decrease in stock price to $17.29 after their Q1 earnings were announced, with a market cap of $2.9 billion.
The decline in Envista Holdings' stock price is directly linked to their Q1 earnings release, indicating potentially disappointing results or outlook.
CONFIDENCE 90
IMPORTANCE 85
RELEVANCE 90
POSITIVE IMPACT
Butterfly Network's stock increased by 18.15% to $0.93 following their Q1 earnings release, with a market cap of $193.5 million.
Butterfly Network's stock price increase is a direct response to their Q1 earnings announcement, suggesting positive investor sentiment.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 90
POSITIVE IMPACT
Pulmonx shares surged 29.5% to $10.0 after announcing Q1 earnings, with a market value of $388.1 million.
The significant rise in Pulmonx's stock price is directly attributed to the positive reception of their Q1 earnings report, indicating strong performance or outlook.
CONFIDENCE 90
IMPORTANCE 85
RELEVANCE 90